Titre:
  • Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
Auteur:Machiels, Jean Pascal; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, Renaud; Lemort, Marc; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Yassine; Quiriny, marie; De Saint Aubain, Nicolas; Clement, Paul M J P.; Coropciuc, R.; Hauben, Esther; Licitra, L.F.
Informations sur la publication:Annals of oncology, 29, 4, page (985-991)
Statut de publication:Publié, 2018-04
Sujet CREF:Cancérologie
Hématologie
Mots-clés:Afatinib
Head and neck cancer
Squamous cell carcinoma
Window of opportunity
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdy013
info:scp/85046702398